Wednesday 20 January 2021

Ropeginterferon alfa-2b vs phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): A multicentre, randomised phase 2 trial - MD Linx

Ropeginterferon alfa-2b vs phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): A multicentre, randomised phase 2 trial  MD Linx

from "phlebotomist" - Google News https://bit.ly/3qAYlBG

No comments:

Post a Comment